Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1.
暂无分享,去创建一个
A. F. Stewart | I. Cózar-Castellano | K. Takane | R. Bottino | A. Balamurugan | Appakalai N. Balamurugan
[1] R. Perfetti,et al. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. , 2003, Endocrinology.
[2] Michael C. Ostrowski,et al. Extra-embryonic function of Rb is essential for embryonic development and viability , 2003, Nature.
[3] A. F. Stewart,et al. Adenovirus-mediated Hepatocyte Growth Factor Expression in Mouse Islets Improves Pancreatic Islet Transplant Performance and Reduces Beta Cell Death* , 2003, The Journal of Biological Chemistry.
[4] A. F. Stewart,et al. Islet Growth Factors , 2003 .
[5] A. F. Stewart,et al. Overexpression of parathyroid hormone-related protein inhibits pancreatic beta-cell death in vivo and in vitro. , 2002, Diabetes.
[6] R. Bottino,et al. Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. , 2002, Diabetes.
[7] D. Scadden,et al. Cell Cycle Entry of Hematopoietic Stem and Progenitor Cells Controlled by Distinct Cyclin-Dependent Kinase Inhibitors , 2002, International journal of hematology.
[8] A. F. Stewart,et al. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. , 2001, Diabetes.
[9] B. Glaser,et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. , 2001, Diabetes.
[10] Charles B. Hall,et al. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. , 2001, The Journal of clinical investigation.
[11] P. Adams. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. , 2001, Biochimica et biophysica acta.
[12] A. F. Stewart,et al. Using β-Cell Growth Factors to Enhance Human Pancreatic Islet Transplantation* , 2001 .
[13] A. F. Stewart,et al. Using beta-cell growth factors to enhance human pancreatic Islet transplantation. , 2001, Journal of Clinical Endocrinology and Metabolism.
[14] M. Seto,et al. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. , 2000, The Journal of clinical endocrinology and metabolism.
[15] V. Godfrey,et al. Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity , 2000, Molecular and Cellular Biology.
[16] C. Rhodes,et al. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. , 2000, Journal of molecular endocrinology.
[17] S. Bonner-Weir,et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. , 2000, Diabetes.
[18] A. F. Stewart,et al. Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia* , 2000, The Journal of Biological Chemistry.
[19] P. Pandolfi,et al. Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27Kip1 Activity , 1999, Molecular and Cellular Biology.
[20] J. Segall,et al. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. , 1999, Endocrine reviews.
[21] M. Barbacid,et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia , 1999, Nature Genetics.
[22] D. Drucker. Glucagon-Like Peptides , 1998, Diabetes.
[23] R. Sorenson,et al. Adaptation of Islets of Langerhans to Pregnancy: β-Cell Growth, Enhanced Insulin Secretion and the Role of Lactogenic Hormones , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[24] A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth. , 1996, Endocrinology.
[25] L. Donehower,et al. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. , 1995, Cancer research.
[26] S. Bonner-Weir,et al. Dynamics of β-cell Mass in the Growing Rat Pancreas: Estimation With a Simple Mathematical Model , 1995, Diabetes.
[27] C. Ricordi. Methods in cell transplantation , 1995 .
[28] T. Jacks,et al. Cooperative tumorigenic effects of germline mutations in Rb and p53 , 1994, Nature Genetics.
[29] C. Newgard,et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. , 1994, Methods in cell biology.
[30] D. Hanahan,et al. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Hanahan,et al. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. , 1985, Nature.
[32] E. B. Jackson,et al. Perspectives on , 1981, J. Am. Soc. Inf. Sci..